抗失眠药达利雷生在阿里健康首发

南方财经网
Sep 04

  南方财经9月4日电,由先声药业引进的全球新一代抗失眠药达利雷生(商品名:科唯可)在阿里健康正式首发。达利雷生是目前唯一获欧洲药品管理局批准的改善日间功能的DORA(双重食欲素受体拮抗剂)类抗失眠药,源于瑞士,由先声药业和Idorsia公司共同研发引进,该药此前已在美国、英国、瑞士、日本、加拿大等11个国家及中国香港获批上市。(21世纪经济报道)

(文章来源:南方财经网)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10